Navigation Links
Mayo Clinic Research on SurgiCount To Be Presented at Conferences
Date:9/23/2010

TEMECULA, Calif., Sept. 23 /PRNewswire/ -- SurgiCount Medical, the wholly-owned operating subsidiary of Patient Safety Technologies, Inc. (OTC Bulletin Board: PSTX), announced that results of independent, unsponsored clinical research conducted by the Mayo Clinic on their multi-year effort to reduce retained foreign objects will be presented and discussed at two upcoming conferences.  The research and related discussion will include the evaluation of the SurgiCount Safety-Sponge® System and its impact on retained surgical sponges at the Mayo Clinic.  

The upcoming conferences are as follows:


  • 23rd Annual Managing Today's OR Suite Conference, Orlando, Florida
    Friday, October 1st, 9:30am – 10:45am
    What Does It Take to Prevent Retained Foreign Objects
    Robert R. Cima, MD, MA
    Vice Chairman, Department of Surgery; Associate Professor of Surgery, Mayo Clinic,
    Rochester, Minnesota
    Cheryl Weisbrod, RN, MSN
    Nurse Administrator, Mayo Clinic
    Sarah R. Pool, RN, MSN
    Resource Nurse Manager, Mayo Clinic, Instructor in Nursing, College of Medicine
    James D. Clark, RN, MSN
    Nursing Education Specialist, Surgical Services, Mayo Clinic

  • American College of Surgeons 96th Annual Clinical Congress, Washington DC
    Tuesday, October 5th, 2:30pm – 4:00pm
    Quality and Outcomes Session I
    Robert R. Cima, MD, MA of the Mayo Clinic will present the clinical research study
    "Evaluation and Implementation of a Bar Coded Sponge Counter System:
    Impact on Retained Sponges After One Year" as part of a discussion panel
  • "We are honored to have our Safety-Sponge® solution validated by extensive, independent research conducted by such a prestigious institution and group of individuals.  To my know
    '/>"/>
    SOURCE Patient Safety Technologies, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2

    Related medicine technology :

    1. For Multiple Myeloma Treatment, More Surveyed European Clinicians Consider the Combination of Immunomodulatory Agents and Proteasome Inhibitors Promising With Respect to Efficacy Than Any Other Drug Regimen Combinations
    2. Clinical Trial Establishes Catheter-Based Aortic Valve Replacement as New Standard of Care for Patients Who Cannot Undergo Surgery
    3. Abbotts Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results
    4. Wolters Kluwer Health and the Joanna Briggs Institute Enter Exclusive Relationship to Deliver Evidence-Based Clinical Resources
    5. Boston Scientific Announces Clinical Data Supporting Safety and Efficacy of Platinum Chromium PROMUS Element™ Stent
    6. OmniComm Systems, Inc. Hosts Autumn 2010 eClinical Forum Meeting
    7. Almacs Clinical Technologies Division Undergoes Successful Joint GCP-GMP MHRA Inspection
    8. immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio
    9. ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD)
    10. Kmart Pharmacy Announces Availability of Flu Shots at Walk-In Flu Clinics
    11. PAREXEL Announces Strategic Functional Service Provider Relationship with Eli Lilly and Company for Clinical Development in Asia/Pacific Region
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/23/2014)... 2014 Galmed Pharmaceuticals Ltd. (Nasdaq: ... focused on the development and commercialization of a ... diseases and cholesterol gallstones, announced today that the ... approved its request for Fast Track Designation of ... Non-Alcoholic Steato-Hepatitis, or NASH.  FDA ...
    (Date:9/23/2014)... 2014  MEDIMETRIKS PHARMACEUTICALS today announced that ... have been elected to Medimetriks, Board of Directors ... who will serve on Medimetriks, Audit Committee, brings ... the Company.  Mr. Lary is currently Managing Director, ... institutional investment firm.  Mr. Lary is responsible for ...
    (Date:9/23/2014)... 23, 2014  Vesselon, Inc. today announced the appointment ... effective September 15, 2014. Dr. Raths, appointment follows Vesselon,s ... agent to market a private preferred Series A round ... treatment. "Jurgen,s deep experience across multiple functional ... asset to Vesselon as we develop our device that ...
    Breaking Medicine Technology:Galmed Pharmaceuticals Announces U.S. FDA Approval of Fast Track Designation of Aramchol for the Treatment of NASH 2Galmed Pharmaceuticals Announces U.S. FDA Approval of Fast Track Designation of Aramchol for the Treatment of NASH 3Medimetriks Pharmaceuticals, Inc. Welcomes Independent Directors Andrew Lary and William Resnick to its Board of Directors 2Vesselon Announces Jurgen Raths, MD to Serve on Board of Directors 2Vesselon Announces Jurgen Raths, MD to Serve on Board of Directors 3
    (Date:9/23/2014)... CONVENE PATHWAYS TO PREVENTION WORKSHOP: ROLE OF OPIOIDS IN ... , The National Institutes of Health is convening a ... evidence on the long-term effectiveness and potential risks of ... the nation,s top experts in the field of pain ... as key NIH scientists who focus on pain related ...
    (Date:9/23/2014)... Dallas, TX (PRWEB) September 23, 2014 ... be taken before making a purchase. It’s difficult to ... and it’s easy for them to manipulate their customers ... mitigate this dilemma, but they tend to lack in ... Consumer Health Reports was founded to fix this ...
    (Date:9/23/2014)... TUESDAY, Sept. 23, 2014 (HealthDay News) -- Both drinking ... risk factors for alcohol abuse by high school students, ... a survey of high school students who drink, could ... those who already drink, to stop them from becoming ... distinguish between age of first alcohol use and progression ...
    (Date:9/23/2014)... York, NY (PRWEB) September 23, 2014 ... congregation on Manhattan’s Upper West Side that embodies ... host Inhabiting Eden: Christians, Scripture and the Ecological ... Tull, A. B. Rhodes Professor Emerita of Old ... the Bible for ancient wisdom that lends insight ...
    (Date:9/23/2014)... the benefits of preventing a reduction in the ... released today by the American College of Physicians ... the Medicaid Primary Care Pay Parity Program: Unless ... Primary Care Will Expire," explains why it is ... and pediatricians (and their related subspecialists), family physicians, ...
    Breaking Medicine News(10 mins):Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 2Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 3Health News:Consumer Health Reports Debuts Revolutionary Review Website 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 3Health News:Inhabiting Eden: Christians, Scripture, and the Ecological Crisis – Public Lecture to Discuss Faith-Based Environmentalism 2Health News:Unless Congress acts, patients may soon lose access to primary care 2Health News:Unless Congress acts, patients may soon lose access to primary care 3
    ... , BUFFALO, N.Y., Dec. 3 To help children ... prevent contracting all forms of influenza, a new animated health education ... , The DVD was created by the Erie Niagara Area Health ... Center (AHEC) program with offices in 40 states. , The U.S. ...
    ... , , TAMPA, Fla., Dec. 3 ... suffer from crippling back and neck pain are putting ... from chronic spinal disorders through minimally-invasive endoscopic surgery is ... Spine Institute (LSI). With surgical facilities in Tampa, ...
    ... , WASHINGTON, Dec. 3 The Redwood ... who are struggling financially and worried about paying for their medicines. ... has helped more than 6 million patients find programs providing prescription ... Prescription Assistance has access to information on more than 475 patient ...
    ... (BBRI) and the University of Pennsylvania have found that ... green tea component EGCG, can prevent and destroy a ... the primary culprits in fatal brain disorders such as ... in the current issue of Nature Chemical Biology ...
    ... , WEDNESDAY, Dec. 2 (HealthDay News) -- The human papillomavirus ... six years, new research has found. , The vaccine guards ... commonly associated with cervical cancer. , The study looked at ... cervical profile and no evidence of HPV infection at the ...
    ... it cut risk factors linked to diabetes, cardiovascular trouble, ... even for just a couple of months, can significantly ... dangerous cluster of heart disease risk factors -- years ... in the journal Diabetes . , In women ...
    Cached Medicine News:Health News:New Animated DVD Helps Children to Better Understand and Prevent Contracting the Flu 2Health News:Give the Gift of Relief for the New Year 2Health News:Green tea chemical combined with another may hold promise for treatment of brain disorders 2Health News:Cervarix Proves Effective Against HPV for Over 6 Years 2Health News:Breast-Feeding Can Help Mom's Heart Decades Later 2Health News:Breast-Feeding Can Help Mom's Heart Decades Later 3
    The Auto Suture DFS stapler is a disposable fascia stapler. The stapler places one staple each time the instrument handles are activated. The staples first penetrate the fascia and are then formed, t...
    ... PROXIMATE RH skin stapler is a full-feature ... assembly., ,PROXIMATE RH has improved visibility ... with a ratchet mechanism for easier staple ... sterile, single patient use instrument designed to ...
    ... PROXIMATE Reloadable Linear Staplers deliver two staggered rows ... sizes. They may be reloaded up to three ... models fire heavy wire staples for thick tissue. ... not interchangeable., ,Benefits include: , Parallel jaw ...
    ... Single Use Loading Units for ... (Single Use Reloadable Staplers with ... Suture™ TA™ Reloadable staplers has ... and thoracic surgical procedures for ...
    Medicine Products: